Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.

about

Influence of VKORC1 and CYP2C9 Polymorphisms on Daily Acenocoumarol Dose Requirement in South Indian Patients With Mechanical Heart Valves.

Item

http://www.wikidata.org/entity/Q47996412

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@en

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@nl

type

Item

label

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@en

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@nl

prefLabel

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@en

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@nl

P1476

Influence of VKORC1 and CYP2C9 ...... With Mechanical Heart Valves.

@en

P2093

C N Manjunath

http://www.w3.org/2001/XMLSchema#string

G Bharath

http://www.w3.org/2001/XMLSchema#string

Rita Christopher

http://www.w3.org/2001/XMLSchema#string

S R Kalpana

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of genetic variants, especially CYP2C9 and VKORC1, on the pharmacology of warfarin

Frequency of cytochrome P450 CYP2C9 variants in a Turkish population and functional relevance for phenytoin

Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data.

A novel functional VKORC1 promoter polymorphism is associated with inter-individual and inter-ethnic differences in warfarin sensitivity.

Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients

Genetic polymorphism of cytochrome P450 2C9 in a Caucasian and a black African population.

Determinants and measures of quality in oral anticoagulation therapy.

Cytochrome P450 2C9 (CYP2C9) and vitamin K epoxide reductase (VKORC1) genotypes as determinants of acenocoumarol sensitivity.

Differential effects of 2C9*3 and 2C9*2 variants of cytochrome P-450 CYP2C9 on sensitivity to acenocoumarol.

Effect of CYP2C9, VKORC1, CYP4F2 and GGCX genetic variants on warfarin maintenance dose and explicating a new pharmacogenetic algorithm in South Indian population.

P304

876-882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/1076029616655617

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27335128

http://www.w3.org/2001/XMLSchema#string